SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
ROIC: Strong ReturnsExpanding
Percentile Rank67
Studio
Year-over-Year Change

Return on invested capital

Percentile
P67
Within normal range
vs 5Y Ago
-0.7x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025-30.02%+74.1%
2024-115.89%-128.2%
2023-50.78%+34.5%
2022-77.51%-234.4%
2021-23.18%-153.1%
202043.61%+177.1%
2019-56.57%-